Community actions
-
Holding
-
Recently bought
-
Recently sold
Bio-Rad Laboratories, Inc. Class A news
-
Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (vs US$3.65 in 3Q 2023)
-
Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
-
BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket
-
Bio-Rad Laboratories Inc (BIO) Q3 2024 Earnings Call Highlights: Strong Clinical Diagnostics ...
-
Bio-Rad Laboratories (BIO) Beats Q3 Earnings and Revenue Estimates
-
What to Expect From These 3 MedTech Stocks This Earnings Season
-
Shareholders in Bio-Rad Laboratories (NYSE:BIO) have lost 58%, as stock drops 4.6% this past week
Recent Motivations
-
Wille Lundqvist
Bought1 shares of
-
💡 Litar på magkänslan
-
-
Ruslan Basarab
Sold1 shares of
-
💵 Освобождаю немного SprinkleБаксов
-
-
Ruslan Basarab
Bought1 shares of
-
💡 Доверяю своему шестому чувству
-
-
Kourtney Fiorucci
Bought3 shares of
-
💡 Trusting my gut feeling
-
-
Michael Mettetal
Sold2 shares of
-
💵 Freeing up some SprinkleBucks
-